TDB–High sulfate dextran
CAS number: 9011-18-1
Dextran sulfate is supplied as a white powder which dissolves freely in water or
salt solutions giving a clear solution.
Dextran sulfates may be produced with a wide range of molecular weights and
degrees of sulfation. Each of the products within this range is supplied with
sulphur contents of 16-20%. Dextran sulfates act as potent polyanions and offer
many interesting pharmacological and biophysical properties. Some examples of
the areas of application are given below
- Cosmetics formulations
- Stabilisation of sensitive biopolymers during processing or formulation
- Enzyme activation or inhibition
- Anti-viral preparations
- Acceleration of hybridisation
High sulfate dextran
CAS Number: 9011-18-1
Dextran sulfates are produced by sulfating selected dextran fractions. TdB Labs produce high sulfated dextran sulfates from 5 kDa to 2000 kDa.
The dextran sulfate is supplied as the sodium salt and is stabilised by a small addition of phosphate salts. A certificate of analysis is supplied with each batch. The molecular weight range, sulfur content, moisture etc. are carefully controlled.
Can’t find what you are looking for? We can always produce a customised product for you. Read more here.
Structure
Dextran is a polysaccharide derived from the bacterium Leuconostoc mesenteroides B512F and consists of an α-D-(1 – 6) linear glucan with a low content (ca. 5%) of sidechains linked to the 3-carbon of glucose. Dextran sulfate is a sulfated derivative of selected dextran fraction. The degree of sulfatation of our high sulfated dextran sulfates lies between 16 to 20 %.
Storage and Storage and stability
Dextran sulfate is stable for more than 6 years when stored dry in well-sealed containers at ambient temperature
Solubility
Dextran sulfate is readily soluble in water.
Applications
Dextran sulfate have a wide range of applications areas and properties. Some examples are:
Read more about application areas here.
-
Anti-coagulation agent in cell media
-
Selective precipitation of lipoproteins
-
Acceleration of DNA hybridisation.
-
Releasing DNA from DNA-histones complexes
-
Inhibition tRNA-binding to ribosomes
-
Inhibition of ribonucleases
-
Anti-viral properties
-
Used in cosmetics for anti-inflammation properties and osmotic retention of water
-
Separation of microorganisms and macromolecules
-
Adjuvant in vaccines
-
Studies of perm selectivity of membranes
Catalog no | Name | MW (Da) | Packsize |
DB004 | Dextran sulfate 5 | 5000 | 10g |
DB004 | Dextran sulfate 5 | 5000 | 100g |
DB008 | Dextran sulfate 10 | 10000 | 10g |
DB008 | Dextran sulfate 10 | 10000 | 100g |
DB012 | Dextran sulfate 20 | 20000 | 10g |
DB012 | Dextran sulfate 20 | 20000 | 100g |
DB016 | Dextran sulfate 100 | 100000 | 10g |
DB016 | Dextran sulfate 100 | 100000 | 100g |
DB050 | Dextran sulfate 500 | 500000 | 10g |
DB050 | Dextran sulfate 500 | 500000 | 100g |
DB054 | Dextran sulfate 2000 | 2000000 | 10g |
DB054 | Dextran sulfate 2000 | 2000000 | 100g |
References
Have you cited this product in a publication? Let us know so we can reference it.
Click to view publications
- Möhwald, M. et al. Aspherical, Nanostructured Microparticles for Targeted Gene Delivery to Alveolar Macrophages. Adv Healthc Mater 6, (2017).
- Dijk, M. et al. How Dextran Sulfate Affects C1-inhibitor Activity: A Model for Polysaccharide Potentiation. Structure 24, 2182–2189 (2016).
- Shahraz, A. et al. Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages. Scientific Reports 5, 16800 (2015).
- Svensjö, E., Nogueira de Almeida, L., Vellasco, L., Juliano, L. & Scharfstein, J. Ecotin-Like ISP of L. major Promastigotes Fine-Tunes Macrophage Phagocytosis by Limiting the Pericellular Release of Bradykinin from Surface-Bound Kininogens: A Survival Strategy Based on the Silencing of Proinflammatory G-Protein Coupled Kinin B2 and B1 Receptors. Mediators of Inflammation https://www.hindawi.com/journals/mi/2014/143450/abs/ (2014) doi:10.1155/2014/143450.
- Parraga, J. E., Zorzi, G. K., Diebold, Y., Seijo, B. & Sanchez, A. Nanoparticles based on naturally-occurring biopolymers as versatile delivery platforms for delicate bioactive molecules: An application for ocular gene silencing. International Journal of Pharmaceutics 477, 12–20 (2014).
- Svensjö, E. et al. Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1–CXCR1/2-pathway. Microvascular Research 83, 185–193 (2012).
- Russo, L. M. et al. Renal Processing of Albumin in Diabetes and Hypertension in Rats. AJN 23, 61–70 (2003).
- Landauer, K. et al. Influence of Carboxymethyl Dextran and Ferric Citrate on the Adhesion of CHO Cells on Microcarriers. Biotechnology Progress 19, 21–29 (2003).
- Hugerth, A. M. Micropolarity and Microviscosity of Amitriptyline and Dextran Sulfate/Carrageenan‐Amitriptyline Systems: The Nature of Polyelectrolyte–Drug Complexes. Journal of Pharmaceutical Sciences 90, 1665–1677 (2001).
- Persson, B., Hugerth, A., Caram-Lelham, N. & Sundelöf, L.-O. Dextran Sulfate−Amphiphile Interaction; Effect of Polyelectrolyte Charge Density and Amphiphile Hydrophobicity. Langmuir 16, 313–317 (2000).
- Hugerth, A. & Sundelöf, L.-O. Effect of Polyelectrolyte Counterion Specificity on Dextran Sulfate−Amphiphile Interaction in Water and Aqueous/Organic Solvent Mixtures. Langmuir 16, 4940–4945 (2000).
- Burne, M. J. et al. Anomalous decrease in dextran sulfate clearance in the diabetic rat kidney. American Journal of Physiology-Renal Physiology 274, F700–F708 (1998).
- Caram‐Lelham, N., Hed, F. & Sundelöf, L.-O. Adsorption of charged amphiphiles to oppositely charged polysaccharides—A study of the influence of polysaccharide structure and hydrophobicity of the amphiphile molecule. Biopolymers 41, 765–772 (1997).
- Vyas, S. V., Burne, M. J., Pratt, L. M. & Comper, W. D. Glomerular Processing of Dextran Sulfate during Transcapillary Transport. Archives of Biochemistry and Biophysics 332, 205–212 (1996).
- Wells, X. E. & Dawes, J. Role of the Liver and Kidney in the Desulphation of Heparin in vivo. Thromb Haemost 74, 667–672 (1995).
- Vyas, S. V., Parker, J.-A. & Comper, W. D. Uptake of dextran sulphate by glomerular intracellular vesicles during kidney ultrafiltration. Kidney International 47, 945–950 (1995).
Technical documents
-
SDS
-
Datafile
Specifications
-
Dextran sulfate 5 HS
-
Dextran sulfate 10 HS
-
Dextran sulfate 20 HS
-
Dextran sulfate 100 HS
-
Dextran sulfate 500 HS
-
Dextran sulfate 2000 HS
How to order
Please visit our webshop to see the molecular weights and pack sizes available. For quotes, request or bulk orders, please send an e-mail to order@tdblabs.se.
Applications
Dextran sulfate have a wide range of applications areas and properties. Some examples are:
Read more about application areas here.
-
Anti-coagulation agent in cell media
-
Selective precipitation of lipoproteins
-
Acceleration of DNA hybridisation.
-
Releasing DNA from DNA-histones complexes
-
Inhibition tRNA-binding to ribosomes
-
Inhibition of ribonucleases
-
Anti-viral properties
-
Used in cosmetics for anti-inflammation properties and osmotic retention of water
-
Separation of microorganisms and macromolecules
-
Adjuvant in vaccines
-
Studies of perm selectivity of membranes